Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NaturalNano is a nanotechnology company specializing in the development and commercialization of proprietary technologies using halloysite nanotubes (HNT). These naturally occurring, hollow nanotubes are utilized to create advanced nanocomposites and controlled-release systems for various industries, including cosmetics, polymers, and drug delivery. The company's primary focus is on its HNT platform, which allows for the encapsulation and precise release of active ingredients, enhancing the performance of consumer and industrial products. While its commercial traction has been strongest in the personal care and materials sectors, the technology offers a versatile platform for the delivery of therapeutic agents in life science applications. The company's intellectual property includes processes for refining and functionalizing these nanotubes for specific industrial and medical uses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NaturalNano.